Golimumab Subcutaneous and Insulin Aspart (Vials)
Determining the interaction of Golimumab Subcutaneous and Insulin Aspart (Vials) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-Insulin Aspart (Vials) (Fiasp)
- Golimumab Subcutaneous-Insulin aspart and insulin aspart protamine
- Golimumab Subcutaneous-Insulin aspart and insulin degludec Subcutaneous
- Golimumab Subcutaneous-Insulin Aspart Injection
- Golimumab Subcutaneous-Insulin Aspart Protamine and Insulin Aspart
- Golimumab Subcutaneous-Insulin aspart protamine and insulin aspart Subcutaneous
- Insulin Aspart (Vials)-GoLYTELY
- Insulin Aspart (Vials)-Gonadorelin
- Insulin Aspart (Vials)-Gonadorelin Intravenous, Injection
- Insulin Aspart (Vials)-Gonadotropin, Chorionic
- Insulin Aspart (Vials)-Gonal-F
- Insulin Aspart (Vials)-Gonal-f RFF